Il mercato dei servizi di fecondazione in vitro è stato valutato a 13.496,29 milioni di dollari nel 2019 e si prevede che raggiungerà 31.613,76 milioni di dollari entro il 2027; si prevede che crescerà a un CAGR dell'11,6% dal 2020 al 2027.
IVF o fecondazione in vitro è una tecnologia riproduttiva pubblicizzata in cui vengono recuperati gli ovuli dalle ovaie di una donna e il campione di sperma di un maschio e diffuso manualmente esternamente in una capsula di vetro da laboratorio. Dopo la fecondazione, questi ovuli fertili vengono sottoposti a coltura embrionale per alcuni giorni e trasferiti nell'utero della stessa donna o di un'altra donna per stabilire una gravidanza di successo.
Il mercato dei servizi di fecondazione in vitro è segmentato in base al tipo di ciclo e all'utente finale. e geografia. In base alla geografia, il mercato è segmentato in Nord America, Europa, Asia Pacifico, Medio Oriente e Stati Uniti. Africa e America meridionale e centrale. Il rapporto offre approfondimenti e analisi approfondite del mercato dei servizi di fecondazione in vitro sottolineando vari parametri quali tendenze di mercato, progressi tecnologici, dinamiche di mercato e analisi del panorama competitivo dei principali attori del mercato in tutto il mondo. Include anche l’analisi dell’impatto del COVID-19 in tutte le regioni. Si stima che il mercato probabilmente crescerà a un ritmo più lento durante il periodo di previsione a causa del calo dei servizi di fecondazione in vitro durante la pandemia di COVID-19 che ha comportato un rigido blocco per alcuni servizi sanitari.
Lucrativo Regioni per il mercato dei servizi di fecondazione in vitro
Approfondimenti di mercato
Aumento dell'incidenza di infertilità
Il tasso di fertilità è in costante calo a livello globale a causa di vari fattori, come la tendenza crescente dei matrimoni tardivi e l’aumento dell’infertilità legata all’età. Si prevede che i tassi di fertilità globale scenderanno a 2,4 bambini per donna entro il 2030 e a 2,2 bambini per donna entro il 2050. Negli Stati Uniti circa il 12% delle donne di età compresa tra 15 e 44 anni ha avuto difficoltà a rimanere incinta o a portare a termine la gravidanza, indipendentemente dallo stato civile. . Inoltre, negli Stati Uniti circa il 6,0% delle donne sposate di età compresa tra 15 e 44 anni non riesce a rimanere incinta dopo un anno di tentativi (infertilità). Secondo il National Center for Health Statistics, il tasso di natalità degli Stati Uniti nel 2018 è stato stimato in 11.968 nascite ogni 1.000 persone, un calo dello 0,95% rispetto al 2017. Inoltre, le malattie da clamidia causano circa 4-5 milioni di infezioni ogni anno negli Stati Uniti. Se non viene trattata in tempo, può causare infertilità sia negli uomini che nelle donne.
Inoltre, secondo il World Fertility Report 2019, sono disponibili stime dei tassi di natalità delle adolescenti per il periodo 2015-2020 per 201 paesi o aree con popolazioni di almeno 90.000 abitanti. Rapidi decadimenti della fertilità sono stati osservati in tutte le principali regioni. Tra i 77 paesi e aree in cui la fertilità adolescenziale è diminuita di oltre il 50% tra il 1990-1995 e il 2015-2020, 28 erano in Europa, 28 in Asia, 8 in Africa (Algeria, Botswana e altri), 7 nei Caraibi (Bahamas, Porto Rico, Grenada, Aruba, Martinica, Santa Lucia e Isole Vergini americane), 4 in Oceania (Guam, Kiribati, Micronesia e Nuova Caledonia), Canada e Stati Uniti. Pertanto, il calo del tasso di fertilità porta a un aumento significativo della domanda di servizi di fecondazione in vitro (IVF) che determinano la finestra di fertilità nei maschi e nelle femmine.
Approfondimenti basati sul tipo di ciclo
In base al tipo di ciclo, il mercato dei servizi di fecondazione in vitro è segmentato in cicli di fecondazione in vitro freschi, cicli di fecondazione in vitro scongelati e cicli di fecondazione in vitro di ovociti donati. Il segmento dei cicli di fecondazione in vitro freschi ha detenuto la quota maggiore del mercato nel 2019 e si prevede che lo stesso segmento registrerà il CAGR più elevato sul mercato durante il periodo di previsione.
Mercato globale dei servizi IVF, per tipo di ciclo: 2019 e 2027Approfondimenti basati sull'utente finale
In base all'utente finale, il mercato dei servizi di fecondazione in vitro è segmentato in ospedali, cliniche per la fertilità, centri chirurgici e istituti di ricerca clinica . Il segmento delle cliniche per la fertilità ha detenuto la quota maggiore del mercato nel 2019; e si prevede che lo stesso segmento registrerà un CAGR nel mercato nel corso del 2020-2027.
Approfondimenti strategici
Strategie inorganiche come partnership e fusioni e le acquisizioni sono comunemente adottate dalle aziende per soddisfare la domanda in evoluzione dei clienti e mantenere i propri servizi migliorati in tutto il mondo. Gli operatori di mercato che operano nel mercato dei servizi di fecondazione in vitro adottano anche strategie organiche come il lancio e l'espansione dei prodotti per espandere la propria presenza e il portafoglio di prodotti in tutto il mondo e per soddisfare la crescente domanda.
Per tipo di ciclo
- Cicli di fecondazione in vitro a fresco
- Cicli di fecondazione in vitro scongelati
- Cicli di fecondazione in vitro di ovuli di donatrice
Per Utente finale
- Cliniche per la fertilità
- Ospedali
- Centri chirurgici e istituti di ricerca clinica
Per area geografica
- Nord America
- Stati Uniti
- Canada
- Messico
- Europa< ul>
- Francia
- Germania
- Italia
- Regno Unito
- Spagna
- Resto d'Europa
- Cina
- India
- Corea del Sud
- Giappone
- Australia
- Resto dell'APAC
- Sudafrica
- Arabia Saudita
- EAU
- Resto del MEA
- Brasile
- Argentina
- Resto dello SCAM
Profili aziendali
- Max Healthcare
- Bloom IVF
- CCRM Fertility.
- OXFORD FERTILITY
- Crea salute (crea fertilità)
- Medicover
- Clinica per la fertilità Aevitas
- Clinica per la fertilità BIOART
- Prelude Fertility, Inc.
- Dono della vita
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
IVF or in-vitro fertilization is a hyped reproductive technology in which the ova from woman's ovaries and the sperm sample from a male is retrieved and manually diffused externally in a laboratory glass dish. After the fertilization these fertile eggs undergo embryo culture for a few days and transferred to the same or another woman's uterus in order to establish a successful pregnancy.
Key factors that are driving growth of the market are increasing incidence of infertility, rising number of fertility clinics and infertility services with government support and growing number of products launches and developments. However, the high procedural cost of reproductive techniques and risks associated with infertility treatment hinders the market growth. Moreover, the increasing trend of delayed pregnancy is contributing to the higher adoption of IVF techniques.
The cost of IVF service depends upon the IVF cycle performed, which nearly starts from US$ 15,000 or more. The cost may further increase along with the associated procedures such as ultrasounds, blood tests, lab work, and embryo storage among others.
The List of Companies - IVF Services Market
- Max Healthcare
- Bloom IVF
- CCRM Fertility.
- OXFORD FERTILITY
- Create Health (Create Fertility)
- Medicover
- Aevitas Fertility Clinic
- BIOART Fertility Clinic
- Prelude Fertility, Inc.
- Gift ov life
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Mar 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Mar 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Mar 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)